Spears Kelvin

SEC Form 4 insider trading activity

Spears Kelvin has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 4, 2026.

On the most recent filing, Spears Kelvin is listed as Director at Nutex Health Inc. Inside the rolling window, Spears Kelvin reported 1 open-market purchase totaling $945 in NUTX and no open-market sales.

Companies traded

Other insiders at NUTX

Insider Buying

$945

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
NUTX
Spears Kelvin
Purchase$945Mar 18SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Spears Kelvin made?

Spears Kelvin has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.

Which companies does Spears Kelvin trade?

Spears Kelvin has filed SEC Form 4 disclosures for 1 company, including NUTX.

When was Spears Kelvin's most recent SEC Form 4 filing?

Spears Kelvin's most recent SEC Form 4 filing on Tracefour is dated Jun 4, 2026.

What is Spears Kelvin's total buy and sell value in the current window?

Inside the rolling retention window, Spears Kelvin bought $945 and sold $0 based on SEC Form 4 filings.

What was Spears Kelvin's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 10 NUTX shares on 2026-03-17, worth $945, per SEC Form 4 filings.